Biological actions of human somatotrophin and its derivatives on mouse mammary gland and teleost urinary bladder.
These studies are concerned with the structural and functional evolution of the ancestrally related pituitary prolactins and somatotrophins. Prolactin-like biological activities of human somatotrophin (hGH) and its peptide fragments were bioassayed in vitro on the mouse mammary gland and the teleost urinary bladder. Plasmin modified-hGH was as active as hGH in both bioassays. The NH2-terminal 134-residue fragment possessed about 10% of the lactogenic and urinary bladder potency of hGH, whereas the CO2H-terminal 51-residue fragment was inactive at the concentrations observed. These results suggest that the same regions of primary structure are responsible for the prolactin-like actions of hGH on the target organs of lower and higher vertebrates. Alteration of the tertiary structure of hGH, human chorionic somatomammotrophin, and ovine prolactin by performic acid oxidation destroys the mammary gland activities of these hormones.
D000818:Animals; D005341:Fibrinolysin / Q000494:pharmacology; D005399:Fishes; D013006:Growth Hormone / Q000494:pharmacology*; D006801:Humans; D008321:Mammary Glands, Animal / Q000187:drug effects*; D051379:Mice; D011388:Prolactin / Q000494:pharmacology*; D001743:Urinary Bladder / Q000187:drug effects*
D011388:Prolactin; D013006:Growth Hormone; D005341:Fibrinolysin